Dear ISA 2022 attendees,
As we near the end of 2022, we would like to express our deep gratitude for your participation in and support of ISA 2022. Fortunately, our meeting was not significantly damaged by the world-wide pandemic, the war in Europe and the financial crisis, and we were happy to come together in Heidelberg and online.
Our first hybrid meeting was a great success, with participants from 50 countries. Eight hundred and forty-two of you traveled to Heidelberg, and another 246 participated actively online. There were 25 lectures, 71 oral presentations, 309 poster presentations and 8 satellite symposia.
Reviewers, chairs, speakers, and the audience all did their part to highlight and focus on the strong scientific progress in the amyloidosis field, but also found the time to connect with old and new friends to strengthen our networks.
We want to thank all the people here in Heidelberg who helped us organize everything before and during the meeting: Jörg Kraus and his team at UniKT, Pyxea (technical support), physicians and doctoral students from the Amyloidosis team and last but not least Marie Brumma, who handled all logistical issues from our sponsor companies.
We hope you will join ISA or renew your membership in 2023 — one of the benefits of membership is access to recordings of all ISA 2022 sessions.
Finally, we would like your feedback about ISA 2022 to help ISA and the Organizing Committee at Mayo Clinic prepare for ISA 2024. We ask you to take a few minutes to fill out our short questionnaire and send it back to us .
With our best wishes for the year to come,
Stefan Schönland and Ute Hegenbart
Markus Weiler and Fabian aus dem Siepen
Carlos Fernández de Larrea, Maria Teresa Cibeira, and Giovanni Palladini